News Coverage 07.09.20 Share on Twitter Share on Facebook Share on LinkedIn How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease Related Announcement PICI Network Researchers to Present #SITC22 Announcement Dana-Farber and Gladstone Institutes Join PICI Network Announcement, Our Impact Parker Institute Researchers Featured at #CICON22